News
Steven Charles Eror has been Inducted into the Prestigious Marquis Who's Who Biographical Registry
Charanjit Singh Joins Solo-Dex, Inc. Board of Directors
Solo-Dex Nominated for Prestigious 2023 Prix Galien USA Awards
Solo-Dex, Inc. Strikes Groundbreaking Master Distributor Agreement with CH Trading Group LLC and Farouk, Maamoun Tamer & Co. for the Distribution of its Fascile(R) Non-Opioid Acute Pain Management Suite in the Kingdom of Saudi Arabia
Industry Leading Acute Pain Management Products To Be Made Available in New Markets in the Middle East and North Africa (Mena) and Beyond, As Solo-Dex Announces Exclusive Distribution Agreement With CH Trading Group
COVID-19 driving the move to regional anesthesia
Solo-Dex CEO Steven C. Eror Says Covid-19 Shows Value of Regional Anesthesia
Steven Eror of SOLO-DEX- In Light Of The Pandemic, Here Are The 5 Things We Need To Do To Improve The US Healthcare System
Solo-Dex Facile® Peripheral Nerve Block Catheter Is Now Nationally Available
CEO CORNER: Steven C. Eror, CEO, Solo-Dex Inc.
Solo-Dex’s CEO Steven C. Eror Participating in 46th Annual Regional Anesthesiology and Acute Pain Medicine Meeting
Virtual Patent Marking
Protected by one or more patents; patents pending. This website is provided to satisfy the virtual patent marking provisions of various jurisdictions including the virtual patent marking provisions of the America Invents Act and provide notice under 35 U.S.C. § 287 (a).
The following list of products and patents may not be all inclusive. For example, some products listed here may be covered by patents in the United States and elsewhere that are not listed, and other products not listed here may be protected by one or more patents in the United States and elsewhere.
Patents include US 8,986,283 / US 9,668,654 / US 10,238,830 / US 10,315,002 / US 10,238,830 / US 10,315,003 / US 2680920 / US 602012035727.4
Applicable to Solo-Dex Facile continuous peripheral nerve block catheters displayed on https://www.solo-dex.com/products